# Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients

> **NCT07639359** · PHASE2 · RECRUITING · sponsor: **Hospital Italiano de Buenos Aires** · enrollment: 50 (estimated)

## Conditions studied

- Critical Illness
- Depressive Symptoms

## Interventions

- **DRUG:** Ketamine (0.5 mg/kg)
- **OTHER:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07639359
- **Lead sponsor:** Hospital Italiano de Buenos Aires
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-14
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639359, "Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07639359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*